ITGA4/CD49d (Natalizumab biosimilar) Antibody from ABBEXA LTD

Search, find, compare suppliers for anti-ITGA4/CD49d (Natalizumab biosimilar) antibody, protein, ELISA kits.

Edit 
Antigenic SpecificityITGA4/CD49d (Natalizumab biosimilar)
Clonemonoclonal
Host SpeciesRecombinant Human
Reactive Specieshuman
IsotypeIgG4 kappa
FormatProtein A/G purified
Size100 µg, 1 mg,
Concentrationtypically between 0.5-2.0 mg/ml.
ApplicationsELISA, WB
Reviews / RatingsIf you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY.
DescriptionNatalizumab is a monoclonal antibody biosimilar expressed in CHO cells, targeting ITGA4/CD49d, for use in laboratory research applications. This product is not suitable for use as medicines or in human, therapeutic or diagnostic applications.

Natalizumab is a recombinant, humanized monoclonal antibody, binds to ?4?1-integrin and blocks its interaction with vascular cell adhesion molecule-1 (VCAM-1). Natalizumab can be used for the treatment of relapsing remitting multiple sclerosis and Crohn's disease. Natalizumab is also the first targeted therapy which blocks an essential mechanism for lymphocyte entry to the CNS and thus prevents acute demyelinating relapses.
Immunogenn/a
Other NamesNatalizumab, ITGA4/CD49d, 189261-10-7
Gene, Accession #CAS: 189261-10-7
Catalog #abx831019
Priceplease inquire
Order / More InfoITGA4/CD49d (Natalizumab biosimilar) Antibody from ABBEXA LTD
Product Specific Referencesn/a
ABBEXA LTD
ABBEXA LTD
ABBEXA LTD
181 Cambridge Science Park
Cambridge, CB4 0GJ UK
P: +44 (0) 1223 755950

Customer Service: info@abbexa.com
Technical Support: support@abbexa.com
Orders: orders@abbexa.com

https://www.abbexa.com

U.S. Office
118 Eldridge Rd, Suite C,
Sugar Land, TX 77478 USA
Telephone: +1 832 327 7413

Netherlands Office
Abbexa BV
Wattstraat 54 2723 RD,
Zoetermeer,Netherlands
Telephone: +44 (0) 1223 755950


Profile of ABBEXA LTD
Return to Antibodies

© 1980 - 2024 Linscott's Directory, Linscott's USA. All rights reserved.